People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Magstim Group Inc | — | Other | Series B | $32.1M | $532.6M | 2015 |
| AngioScore Inc. | — | Other Health Care | Series A | $12.0M | $242.2M | 2011 |
Thomas A. Raffin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas A. Raffin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| J. Matthew Mackowski | 1 | 4 |
| Benjamin S. Schapiro | 1 | 4 |
| Lisa S. Suennen | 1 | 2 |
| Jeanette M. Welsh | 1 | 1 |
| Dalia A. Megiddo | 1 | 1 |
| Thomas R. Trotter | 1 | 1 |
| J. Neal B. Armstrong | 1 | 1 |
| James B. Andrews | 1 | 1 |
| Scott A. Halsted | 1 | 1 |
| Robert A. Elliott | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.